drugset / Trial / NCT00230776

A Controlled Pregabalin Trial In Fibromyalgia

NCT00230776

Phase 3 Completed 740 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of pregabalin compared with placebo for the relief of pain associated with fibromyalgia and improvement of function of patients with fibromyalgia

Timeline

Start
2005-10
Primary completion
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule

Indications